Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China.
National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China.
Front Immunol. 2021 Nov 24;12:783616. doi: 10.3389/fimmu.2021.783616. eCollection 2021.
Idiopathic inflammatory myopathy (IIM) is a heterogeneous group of acquired, autoimmune muscle diseases characterized by muscle inflammation and extramuscular involvements. Present literatures have revealed that dysregulated cell death in combination with impaired elimination of dead cells contribute to the release of autoantigens, damage-associated molecular patterns (DAMPs) and inflammatory cytokines, and result in immune responses and tissue damages in autoimmune diseases, including IIMs. This review summarizes the roles of various forms of programmed cell death pathways in the pathogenesis of IIMs and provides evidence for potential therapeutic targets.
特发性炎性肌病(IIM)是一组获得性、自身免疫性肌肉疾病,其特征为肌肉炎症和肌肉外表现。目前的文献表明,细胞死亡失调与清除坏死细胞功能障碍共同导致自身抗原、损伤相关分子模式(DAMPs)和炎症细胞因子的释放,从而在包括 IIM 在内的自身免疫性疾病中引发免疫反应和组织损伤。本综述总结了各种形式的程序性细胞死亡途径在 IIM 发病机制中的作用,并为潜在的治疗靶点提供了依据。